TheraRadar
← Back
Data updated: Jul 17, 2026

HERITAGE PHARMS INC

Generics
Pharmaceuticals

HERITAGE PHARMS INC is a generic drug manufacturer with 8 FDA-approved products.

1972
Since
8
Drugs
-
Trials
0
New Drugs (2yr)

HERITAGE PHARMS INC's Key Drugs

HERITAGE PHARMS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

HERITAGE PHARMS INC's Recent FDA Approvals

New NDA/BLA approvals for HERITAGE PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

HERITAGE PHARMS INC's Therapeutic Areas

Disease areas where HERITAGE PHARMS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

HERITAGE PHARMS INC Pipeline Snapshot

Active clinical trials for HERITAGE PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling